Literature DB >> 11446768

Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas.

M Saghizadeh1, M Chwa, A Aoki, B Lin, A Pirouzmanesh, D J Brown, A V Ljubimov, M C Kenney.   

Abstract

The purpose of this study was to identify the growth factors and cytokines present in normal and diseased corneas. Total RNA was isolated from normal and diseased corneas. cDNA was synthesized from individual corneas and semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was performed with primers to IL-1alpha, 1IL-8, PDGF-B, BMP-2, BMP-4, IGF-I, TGF-beta2, FGF-2, and VEGF. After normalization to beta2-microglobulin, several factors were identified that were significantly different from normal. Antibodies to IGF-I, BMP-2, VEGF and TGF-beta2 were used for immunohistochemistry. A total of 93 corneas were used for this study including 31 normal, 20 keratoconus, 19 bullous keratopathy (pseudophakic and aphakic, PBK/ABK), and 23 diabetic corneas. The VEGF RNA levels were significantly decreased in the keratoconus and PBK/ABK corneas but increased in the diabetic corneas. BMP-2 gene expression was lower than normal in the PBK/ABK and diabetic corneas. IGF-I and BMP-4 RNA levels were increased in PBK/ABK. In the immunohistochemical studies, the protein patterns paralleled those found at the mRNA level. The only exception was IGF-I in diabetic corneas that showed increased staining in the epithelium and its basement membrane without a significant increase in mRNA levels. TGF-beta2 mRNA and protein levels were similar to normal in all diseased corneas. Thus, no alterations in the tested growth factors/cytokines were unique to keratoconus corneas. In contrast, PBK/ABK corneas had specific significant elevations of BMP-4 and IGF-I. Diabetic corneas were unique in their increased VEGF mRNA levels. These data suggest that while some growth factor/cytokine alterations are non-specific and can be found in multiple corneal diseases, there are others that are unique to that disease. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11446768     DOI: 10.1006/exer.2001.1028

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  19 in total

Review 1.  Diabetic complications in the cornea.

Authors:  Alexander V Ljubimov
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

2.  Tear film inflammatory mediators in patients with keratoconus.

Authors:  Rana Sorkhabi; Amir Ghorbanihaghjo; Nazli Taheri; Mohammad Hosein Ahoor
Journal:  Int Ophthalmol       Date:  2014-07-26       Impact factor: 2.031

3.  Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas.

Authors:  Mehrnoosh Saghizadeh; Andrei A Kramerov; Jian Tajbakhsh; Annette M Aoki; Charles Wang; Ning-Ning Chai; Julia Y Ljubimova; Takako Sasaki; Gabriel Sosne; Marc R J Carlson; Stanley F Nelson; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

4.  Transforming growth factor-β signaling pathway activation in Keratoconus.

Authors:  Christoph Engler; Shukti Chakravarti; Jefferson Doyle; Charles G Eberhart; Huan Meng; Walter J Stark; Clare Kelliher; Albert S Jun
Journal:  Am J Ophthalmol       Date:  2011-02-18       Impact factor: 5.258

5.  Targeting growth factor supply in keratopathy treatment: comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops.

Authors:  Piera Versura; Marina Buzzi; Giuseppe Giannaccare; Adriana Terzi; Michela Fresina; Claudio Velati; Emilio C Campos
Journal:  Blood Transfus       Date:  2015-07-09       Impact factor: 3.443

6.  Differential expression of transforming growth factor-beta isoforms in bullous keratopathy corneas.

Authors:  Barbara Strzalka-Mrozik; Agnieszka Stanik-Walentek; Malgorzata Kapral; Malgorzata Kowalczyk; Jolanta Adamska; Joanna Gola; Urszula Mazurek
Journal:  Mol Vis       Date:  2010-02-05       Impact factor: 2.367

7.  Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met gene.

Authors:  Mehrnoosh Saghizadeh; Andrei A Kramerov; Fu-Shin X Yu; Maria G Castro; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

8.  A comparative study of risk factors for corneal infection in diabetic and non-diabetic patients.

Authors:  Bin Wang; Shuo Yang; Hua-Lei Zhai; Yang-Yang Zhang; Chun-Xia Cui; Jun-Yi Wang; Li-Xin Xie
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

9.  Adenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes.

Authors:  Mehrnoosh Saghizadeh; Andrei A Kramerov; Yousha Yaghoobzadeh; Jinwei Hu; Julia Y Ljubimova; Keith L Black; Maria G Castro; Alexander V Ljubimov
Journal:  Brain Res Bull       Date:  2009-10-12       Impact factor: 4.077

Review 10.  Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.

Authors:  Patricia J McLaughlin; Joseph W Sassani; Matthew S Klocek; Ian S Zagon
Journal:  Brain Res Bull       Date:  2009-08-14       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.